JPRN-UMIN000040371招募中未知
Efficacy of safety of Natural Orifice Specimen Extraction:NOSE for Colorectal cancer - Efficacy of safety of Natural Orifice Specimen Extraction:NOSE for Colorectal cancer
Osaka Medical and Pharmaceutical University0 个研究点目标入组 120 人开始时间: 2020年7月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with or suspicious of estrogen-dependent cancer (eg, breast cancer or gynecologic canbcer) 2)Participants with a history of any hypersensitivity to ingredients in HOLIN-V VAGINAL TABLETS 3)Patients who have the possibility of being pregnant
研究者
相似试验
进行中（未招募）
1 期
AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) - TRANSITmoderate to severe plaque psoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2008-008171-34-SKJanssen-Cilag International NV
进行中（未招募）
不适用
AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) - TRANSITmoderate to severe plaque psoriasisEUCTR2008-008171-34-ITJanssen-Cilag International NV500
进行中（未招募）
1 期
AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) - TRANSITmoderate to severe plaque psoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2008-008171-34-FRJanssen-Cilag International NV
进行中（未招募）
不适用
AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) - TRANSITEUCTR2008-008171-34-DEJanssen-Cilag EMEA Medical Affairs500
进行中（未招募）
1 期
AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) - TRANSITmoderate to severe plaque psoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2008-008171-34-GRJanssen-Cilag International NV500